AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 285: H907-H914, 2003. First published March 27, 2003; doi:10.1152/ajpheart.00856.2002
0363-6135/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/2/H907    most recent
00856.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiechert, S.
Right arrow Articles by Eschenhagen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiechert, S.
Right arrow Articles by Eschenhagen, T.

INNOVATIVE METHODOLOGY

24-h Langendorff-perfused neonatal rat heart used to study the impact of adenoviral gene transfer

S. Wiechert,1 A. El-Armouche,2 T. Rau,2 W. -H. Zimmermann,2 and T. Eschenhagen2

1Institute of Experimental and Clinical Pharmacology, University Erlangen-Nürnberg, 91054 Erlangen, Germany; and 2Institute of Experimental and Clinical Pharmacology, University Hospital Hamburg-Eppendorf, 20246 Hamburg, Germany

Submitted 5 November 2002 ; accepted in final form 27 February 2003


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
The human genome project has increased the demand for simple experimental systems that allow the impact of gene manipulations to be studied under controlled ex vivo conditions. We hypothesized that, in contrast to adult hearts, neonatal hearts allow long-term perfusion and efficient gene transfer ex vivo. A Langendorff perfusion system was modified to allow perfusion for >24 h with particular emphasis on uncompromised contractile activity, sterility, online measurement of force of contraction, inotropic response to {beta}-adrenergic stimulation, and efficient gene transfer. The hearts were perfused with serum-free medium (DMEM + medium 199, 4 + 1) supplemented with hydrocortisone, triiodothyronine, ascorbic acid, insulin, pyruvate, L-carnitine, creatine, taurine, L-glutamine, mannitol, and antibiotics recirculating (500 ml/2 hearts) at 1 ml/min. Hearts from 2 day-old rats beat constantly at 135–155 beats/min and developed active force of 1–2 mN. During 24 h of perfusion, twitch tension increased to ~165% of initial values (P < 0.05), whereas the inotropic response to isoprenaline remained constant. A decrease in total protein content of 10% and histological examination indicated moderate edema, but actin and calsequestrin concentration remained unchanged and perfusion pressure remained constant at 7–11 mmHg. Perfusion with a LacZ-encoding adenovirus at 3 x 108 active virus particles yielded homogeneous transfection of ~80% throughout the heart and did not affect heart rate, force of contraction, or response to isoprenaline compared with uninfected controls (n = 7 each). Taken together, the 24-h Langendorff-perfused neonatal rat heart is a relatively simple, inexpensive, and robust new heart model that appears feasible as a test bed for functional genomics.

functional genomics; heart failure; molecular biology


WITH SUCCESSFUL TERMINATION of the human genome project, the scientific community is faced with about 30,000 genes and an estimated threefold higher number of gene products whose functions in the cell are far from being understood in the vast majority of cases (3, 13, 19). Simple, efficient, and valid assays are crucial to study gene-function relationships. Whereas principal gene functions can easily be studied in vitro or in simple experimental systems such as Xenopus oocytes or mammalian tumor cell lines, the contribution of a single gene or changes in its expression levels to the overall function of an organ or an organism remains difficult to elucidate.

Tremendous progress has been made by transgenic techniques, i.e., the generation of animals overexpressing foreign or modified endogenous genes or carrying an inactivated gene locus (15, 22). Transgenic animals are undisputably the gold standard to study gene-function relationships under (patho)physiological conditions, but limitations remain. First, generation of transgenic animals still requires considerable time and resources that preclude its application as a screening method. Second, despite important progress in conditional transgene expression in terms of timing, organ specificity, and quantity, transgenic techniques are prone to confounders such as developmental and physiological compensations and genetic background. Finally, ethic considerations exist.

In cardiovascular research attempts have been made to create easier and more efficient experimental models that are less prone to compensational responses but yet provide the necessary complex cardiac context. Examples are cultured neonatal rat cardiac myocytes (11), freshly isolated adult cardiac myocytes (5, 6, 16), isolated trabeculae of adenovirus-perfused rabbit hearts (17), injection of adenovirus into neonatal rat hearts in vivo (4), or adenovirus infusion into adult rat hearts in vivo (12). Cells in culture are easily transfected but are either immature or prone to cell isolation and dedifferentiation artifacts. In addition, measurement of force of contraction is indirect at best. More complex systems likely better reflect the physiological situation and allow force measurement, but they require high virus titers, i.e., are expensive and time consuming, require higher technical demands, and have not yet been shown to be applicable as a routine method. Recently, we have introduced the method of engineered heart tissue that may serve as an intermediate between cell culture and animal model by allowing efficient adenoviral gene transfer and measurement of isometric force of contraction (9, 23). However, adenoviral gene toxicity appears to limit its usefulness as a routine method (7). Thus none of the existing systems appears to be a perfect test bed for adenoviral gene transfer. The classic Langendorff heart may be ideally suited for this purpose because it allows measurement of complex cardiac function under relatively physiological conditions. Yet, in hearts from adult animals of various species development of interstitial edema limits perfusion time to maximally 6–8 h, and attempts to circumvent this problem by modifying the perfusion conditions have failed (21). A recent review describes that hypothermic arrest periods cause tissue preservation up to 24 h and longer (20), but no attempts have been made to use this model for genetic testing. We hypothesized that neonatal rat hearts are less sensitive to the artificial conditions of in vitro perfusion with crystalloidal solutions, partly because they are very hypoxia/ischemia resistant (1, 10) and have a less developed vascular system and therefore may serve as a suitable, improved model to study effects of adenoviral gene transfer.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
All procedures were approved by the local animal protection authority (TS-00/20 Pharma) and conformed to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publication 85-23, Revised 1985).

Animals, Langendorff perfusion setup, and medium. A total number of 710 Wistar pups (days 0–7) was used. The mean weight was 7.9 g. Animals received an intraperitoneal injection of heparin (500 units) 10–20 min before being euthanized. After cervical dislocation, hearts were rapidly excised (mean time to perfusion 2.5 min) and mounted on a Langendorff perfusion system (LDH 4103, Föhr Medical Instruments) equipped with a 23-gauge (0.6 mm) needle (Fig. 1, A and B). The system consists mainly of different carbogen-gassed, water-jacketed reservoirs for the medium, a pump, sterile one-way filters, special glass equipment to warm the medium, and a bubble trap directly above the needle holding the heart. The perfusion medium was composed of DMEM + medium 199 4+1, 100 U/ml penicillin (Pen), 100 µg/ml streptomycin (Strep), 2 mmol/l L-glutamine (Biochrom), 5 µg/ml hydrocortisone, 5 mmol/l creatine, 1 nmol/l triiodothyronine, 1.87 µg/ml amphotericin B, 80 mmol/l mannitol (Sigma), 5 mmol/l pyruvate, 2 mmol/l L-carnitine (Fluka), 100 µg/ml ascorbic acid (Roth), 20 IU/l insulin (Aventis), and 5 mmol/l taurine (Applichem). Temperature was maintained at 37°C, and the pH was initially 7.59 ± 0.02 and 7.63 ± 0.02 after 24 h without significant change (n = 8). Force of contraction was measured with a self-made transducer consisting of a beam in bending equipped with four strain gauges (no. 3/350DY11, Hottinger Baldwin Messtechnik). Twitch tension (TT), resting tension, contraction duration (time from 10% to peak force development), and relaxation duration (time to 90% relaxation) were evaluated by BMON software (Ingenieurbüro Jäckel; Hanau, Germany).



View larger version (63K):
[in this window]
[in a new window]
 
Fig. 1. Experimental setup for 24-h Langendorff perfusion of neonatal rat hearts. A: schematic diagram of the setup. 1 and 2, carbogen-gassed, water-jacketed medium reservoirs; 3, one-way sterile filter; 4, pump; 5, water-jacketed organ bath; P, perfusion pressure transducer; SG, force transducer with strain gauges; PC personal computer. B: photograph of a detail of the perfusion setup. BT, bubble trap; LH, Langendorff-perfused heart; SW, steal wire connecting the heart with the force transducer; SG, force transducer with strain gauges.

 

Measures to ensure and to determine sterility. Given that sterility was a major requirement for success, several measures were taken to minimize contamination and growth of germs. At the end of a week, the complete system was thoroughly rinsed with water to remove the medium, cleaned with citric acid (0.1 mol/l) and SDS (10 mmol/l) at 60°C, and subsequently thoroughly rinsed with water. Before the next experiment, the complete device was autoclaved, and new sterile filters were build in. The latter were changed daily. The instruments were stored in 70% ethanol. Handling was performed with gloves to minimize contamination. The organ baths were partly closed with a lid, and the perfusion medium contained Pen-Strep at standard and amphotericin B at one-third of the standard concentration (1.87 µg/ml). After establishment of standard conditions, sterility was tested for 1 wk after each 24-h run. Samples of the perfusion medium were taken directly above the 23-gauge needle holding the heart. Samples were subjected to a standard quantitative bacteriological examination kindly provided by the Institute of Microbiology, University of Erlangen-Nuremberg. This evaluation showed no sign of bacterial or fungal growth.

Heart wet-to-dry weight and protein determination. To determine heart-to-body weight ratios, animals were weighed, and hearts including atria were excised and gently, but thoroughly dabbed between two layers of paper towels either before or after the 24-h perfusion, weighed, and then freeze-dried (24 h) in preweighed Eppendorf cups. To determine protein content using the Bradford method (Bio-Rad), hearts either native or after the 24-h perfusion were homogenized in lysis buffer (Tris, pH 7.5, 25 mmol/l, SDS 5%), further diluted with water, and measured with IgG as standard.

Adenovirus production and titering. The adenovirus coding for bacterial {beta}-galactosidase with a nuclear localization signal (Ad5LacZ) was a kind gift from Y. Fromes, Paris, France. It was propagated in HEK 293 cells and titered on neonatal rat cardiac myocytes as described previously (23). Importantly, the number of biologically active virus (bav) was defined as the virus number necessary to positively transfect (stain blue) a given number of neonatal rat cardiac myocytes in culture. For example, 1 x 106 bav was just sufficient to transfect 1 x 106 cardiac myocytes or 50% of 2 x 106 cardiac myocytes.

Adenoviral gene transfer: standard experiment. The hearts were infected with Ad5LacZ ~3 h after the start of perfusion. To increase gene transfer efficiency (7, 16), the hearts were perfused with medium containing histamine and serotonin (10 µmol/l each) that was drained off after passage through the hearts. After 10 min, the perfusion was stopped and the virus was injected directly into the tube above the heart. Perfusion was started for 1 min, stopped for another 2 min, and periods of continuous and halted perfusion were repeated twice as described by others (7, 16). The medium containing the virus was collected in a 50-ml reservoir and recirculated until the end.

Inotropic response to isoprenaline. In the series of experiments designed to evaluate the influence of a 24-h perfusion on force of contraction and inotropic response to {beta}-adrenergic agonists, isoprenaline was infused for 15 min 3 h after the start of perfusion, the perfusate was drained, isoprenaline was washed out for 20 min, and recirculation was reestablished. This procedure was repeated after 21 h of perfusion. In the series of experiments designed to test the influence of virus infection on {beta}-adrenergic responses, isoprenaline was applied only 21 h after infection. To enlarge the inotropic response, the perfusion medium in this series of experiments was exchanged to a low-calcium (1 mmol/l) Tyrode solution before application of isoprenaline. This reduced force of contraction by ~80% (see Fig. 6) but yielded enhanced inotropic response to isoprenaline.



View larger version (141K):
[in this window]
[in a new window]
 
Fig. 6. Histological analysis of Ad5LacZ-infected 24-h Langendorff-perfused neonatal rat hearts. Photomicrograph of a paraffin section (4 µm) of a {beta}-galactosidase-stained, formaldehyde-fixed (4%, overnight), PBS-rinsed (overnight) heart. Section was counterstained with hematoxylin and eosin. Note that with this technique, histological preservation was superior, but transfection efficiency was underestimated. Bar = 30 µm.

 

Histological procedures. Hearts were fixed in 4% formaldehyde in PBS overnight at 4°C, either directly after excision or after the 24-h perfusion, and subjected to standard paraffin embedding. Slices (4 µm) were cut and stained with hematoxylin and eosin (H&E) according to standard protocols. To determine transfection efficiency after adenoviral gene transfer with Ad5LacZ, hearts were not fixed but immediately frozen in liquid nitrogen and embedded in TissueTek, and 10-µm slices were cut. Sections were washed with PBS, fixed with 70% ethanol for 1 min, washed with PBS twice, and incubated with LacZ assay solution {20 mmol/l K3[Fe(CN)6], 20 mmol/l K4[Fe(CN)6], 2 mmol/l MgCl2· 6H2O, 0.02% Igepal CA-630, 0.01% sodium deoxycholate, and 1 mg/ml X-Gal} for 10 min. Slices were rinsed with PBS, postfixed in 4% formaldehyde in PBS, and counterstained with H&E.

Statistical analysis. Data were calculated as arithmetic means ± SE and analyzed using an unpaired t-test. A P value of <0.05 was considered significant. n indicates the number of independent experiments.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Characterization of the 24-h Langendorff perfusion model sterility. An inherent problem of 24-h perfusions of biological specimens excised under semisterile conditions in a half-open system is bacterial and fungal infection. Indeed, initial experiments with medium containing only Pen-Strep at standard concentrations showed severe contamination in both the medium and the heart. Inclusion of four sterile one-way filters (Fig. 1), exclusive use of silicone tubing and glass connectors, autoclaving the entire unit once a week, i.e., for perfusion of eight hearts, and inclusion of amphotericin B at one-third of the standard concentration eliminated bacterial or fungal growth (10 samples taken during several weeks, data not shown).

Online measurement of beating rate, force of contraction, and perfusion pressure. Force of contraction was measured by connecting a hook in the apex of the perfused heart with a self-made force transducer (Fig. 1). Online recording was interrupted during the night by applying a weight of 4 mN to the apex (removed the next morning) because it was shown to increase the reproducibility of force measurements after 24 h (n = 4, data not shown). Under these conditions (n = 23), the hearts beat at a mean frequency of 145 beats/min 3 h after the start of perfusion and 137 beats/min 24 h after the start of perfusion (Fig. 2A). Isoprenaline (0.1 µmol/l) increased beating rate to 179 beats/min 3 h after the start of perfusion and 168 beats/min 24 h after the start of perfusion (Fig. 2A). Interestingly, force of contraction increased between 3 h and 24 h after the start of perfusion from 1.8 to 2.9 mN (+61%; Fig. 2B). Isoprenaline (0.1 µmol/l) increased force of contraction to 3.7 mN (+106%) 3 h after the start of perfusion and to 4.7 mN (+62%) 24 h after start of perfusion (Fig. 2B). In absolute terms, the increase in force of contraction was similar (1 mN). The perfusion pressure was measured online for 24 h and, after a short equilibration period with slightly higher pressures, remained constant at 1 ml/min (Fig. 2C). Perfusion at 2 ml/min raised pressures to 50 mmHg (declining over time to 30 mmHg) but did not lead to better contractile function after 24 h (n = 7–8 per group; not shown). Because sterile filters obstructed, we found the 1 ml/min rate more suitable.



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2. Functional performance of Langendorff-perfused rat hearts (n = 23) over 24 h. A: spontaneous and isoprenaline-stimulated beating rate 3 h and 24 h after the start of perfusion. bpm, Beats/min. B: spontaneous and isoprenaline-stimulated twitch tension (TT) 3 h and 24 h after the start of perfusion. C: perfusion pressure over the entire 24-h period. *P < 0.05 vs. 3 h.

 

Conditions of perfusion. The medium was designed according to standard cell culture techniques, published protocols (14), and our experience. Not all of the supplements were systematically tested. First, amphotericin B at standard concentration reduced force of contraction below 1 mN or hampered positive inotropic effect of isoprenaline (exclusion criteria) in five of seven experiments. Second, force of contraction and the positive inotropic effect of isoprenaline 24 h after the start of perfusion were 16% and 25% higher in hearts perfused with 1 nM triiodothyronine than with 0.1 nM (Fig. 3). Third, at a later stage of the experiments, a series of experiments showed that omitting insulin from the medium did not affect basal force of contraction but doubled the inotropic response to isoprenaline (n = 6 per group; not shown). Finally, addition of fetal calf serum or albumin was not compatible with the continuous bubbling of the medium.



View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3. Effect of medium composition on contractile function. Spontaneous and isoprenaline-stimulated TT 24 h after start of perfusion in the presence of 0.1 nmol/l (n = 7 hearts) or 1.0 nmol/l (n = 10 hearts) triiodothyronine (T3).

 

Heart wet weight and dry weight, protein concentration, and histology. Given that interstitial edema represents a limiting factor of Langendorff-perfused adult hearts, several parameters were studied to quantify edema in 24-h perfused neonatal rat hearts. As shown in Fig. 4, the dry weight-to-wet weight ratio showed a 10% decrease compared with native, unperfused hearts from animals of similar age (Fig. 4A). Protein concentration decreased from 9.3 to 8.4% (–10%; Fig. 4B). Standard H&E histology showed a less compact tissue structure in the 24-h perfused hearts, an increase in interstitial space, and a decrease in myocyte diameter and eosinophilic staining (Fig. 4, C and D). However, both actin and calsequestrin, two markers of cardiac myocytes, remained unchanged when assayed as such or normalized to GAPDH (Fig. 4E). This indicates that the changes, if present, are minor.



View larger version (69K):
[in this window]
[in a new window]
 
Fig. 4. Tissue properties of 24-h Langendorff perfusion of neonatal rat hearts. A: dry weight-to-wet weight ratio of native and 24-h perfused hearts. B: protein concentration in percentage of wet weight in native and 24-h perfused hearts. n, Number of hearts studied. C: photomicrograph of an hematoxylin and eosin-stained paraffin section of a native neonatal rat heart (day 2). D: 24-h perfused heart of same age; bar = 50 µm. E: representative Western blot and statistical analysis of actin, GAPDH, and calsequestrin (CSQ) in native and 24-h perfused neonatal rat hearts (n = 8 each). P < 0.05 vs. native.

 

Adenoviral gene transfer into 24-h Langendorff-perfused neonatal rat heart. Hearts were perfused with Ad5LacZ in a volume of about 5 ml under three times 2-min stop-flow conditions in the presence of histamine and serotonin. The virus was then recirculated for the rest of the time in a 50-ml volume. These conditions were chosen after initial experiments with different application modes and increasing concentrations of virus and were found to yield a high transfection efficiency throughout the hearts partly excluding the atria (Fig. 5). Importantly, the transfection efficiency of ~80% was stable in seven consecutive experiments. Histologically, {beta}-galactosidase staining showed nuclear concentration, but the myoplasma was stained blue as well (Fig. 6). Virus infection did not affect beating rate (Fig. 7A) or force of contraction under basal or isoprenaline-stimulated conditions compared with uninfected controls studied in parallel (Fig. 7B).



View larger version (106K):
[in this window]
[in a new window]
 
Fig. 5. Transfection efficiency of adenoviral gene transfer into 24-h Langendorff-perfused rat hearts. Photomicrographs of cryo sections from a Ad5LacZ-infected heart, fixed with ethanol, stained for {beta}-galactosidase, postfixed with formaldehyde, and counterstained with hematoxylin and eosin. Right lower corner shows another Ad5LacZ-infected heart stained directly (no fixation) for {beta}-galactosidase and postfixed with formaldehyde. Bar = 1 mm.

 


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7. Effect of Ad5LacZ on contractile function of 24-h Langendorff-perfused neonatal rat hearts (n = 7). A: beating rate and contraction kinetics of hearts 24 h after the start of perfusion in the absence or presence of Ad5LacZ. dF/dt+, maximal increase in force over time (mN/s); dF/dt–, maximal decrease in force over time (mN/s); T1, time from 10% to peak force development; T2, time to 90% relaxation. B: TT and response to isoprenaline 24 h after the start of perfusion in the absence or presence of Ad5LacZ. Force of contraction was determined in normal perfusion medium (medium), 45 min after change of perfusion to low Ca2+ Tyrode solution (tyrode), and 15 min after application of isoprenaline (0.1 µmol/l).

 


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
We developed a new experimental model, the 24-h Langendorff-perfused neonatal rat heart, and showed that it is stable for >24 h and allows highly efficient adenoviral gene transfer at relatively low virus concentration without apparent adverse effect on contractile behavior. It is relatively simple, inexpensive [complete setup ~11,000 Euro (circa $10,330), each run ~22 Euro (circa $21)], and robust, yet relatively complex and physiological and may therefore be suitable as a screening model for studying gene-function relationships ex vivo.

During the establishing phase we found several parameters to be critical. First, air bubbles were avoided by scrupulous control of the tubing. In addition, bubble traps directly above the heart are essential. Second, continuous filtering of the perfusate is necessary when using a recirculating mode and can easily be achieved with one-way filters. Third, sterility is difficult to ensure because the heart is manipulated and is beating in an open reservoir. For logistical reasons we did not perform manipulations under the sterile hood. Thus germs were present from the beginning of the experiment and likely entered the perfusate continuously during the 24 h in a normal cell culture laboratory. We solved this problem by autoclaving the entire perfusion system once a week and by inclusion of Pen-Strep and amphotericin B. The latter was used at one-third of the recommended concentration for cell culture to avoid toxicity. In addition, sterile filters in the circulation were changed for each experiment. Fourth, medium composition is certainly critical, but we did not extensively test different compositions. Instead, we modified an existing protocol (14) according to our cell culture experience. Two statements can be made: increasing triiodothyronine to 1 nmol/l improved contractile preservation, and interestingly, omitting insulin improved the inotropic response to isoprenaline (note that all experiments depicted here have been performed in the presence of insulin). Initial experiments with fetal calf serum did not indicate improvement and added the problem of foaming in the continuously gassed reservoir. Fifth, an important parameter of success is mechanical loading of the heart. We found the hearts to perform better when a constant weight was applied to the apex during most of the perfusion time and if the heart can perform work. Even though we did not systematically study contraction mechanics, it appears obvious that the heart performs "auxotonic" work when lifting a weight with each heart beat. This is more physiological than either an isometric or isotonic mode of contraction. The weight of 4 mN (400 mg) is about 10 times the weight of a neonatal rat heart. Finally, the conditions of virus infection were chosen according to recent studies in adult heart models (8, 18) showing improvement of transfection efficiency with vasodilating receptor agonists such as histamine, serotonin, bradykinin, and vascular endothelial growth factor, as well as by stop flow. We did not systematically study the impact of these parameters on transfection efficiency in our model. One may argue that the stop-flow method induced preconditioning. However, the similar values for force of contraction in the virus-perfused (stop flow) and nonperfused (continued flow; compare Figs. 2 and 3 with 7B) and the fact that 21 h separated stop flow from force measurements argue against a significant impact of this intervention.

Even though most of the parameters studied demonstrated good performance of the model, limitations exist. An obvious, inherent problem of the model is that the neonatal rat heart is immature, e.g., lacks a well-developed sarcoplasmic reticulum/T-tubular system (2). Thus it may not be optimal for studying the impact of sarcoplasmic reticulum-related genes. Moreover, a relatively low heart rate and short action potential differ significantly from the mature rat heart. Second, 24 h of perfusion induced edema, thinning of myocytes, and a reduction in heart weight. This indicates some damage. Yet, with about 10% this effect was relatively modest and apparently did not affect perfusion pressure, contractile function, or beating rate. Actin and calsequestrin concentration also remained constant, arguing against significant myofilament degradation. Accordingly, force of contraction significantly increased. We believe that the latter does not indicate real improvement of contractile force but rather some geometric adaptation to the direction of strain on the heart. This relates to another principal shortcoming of the model, namely that contractile function is not measured by a balloon but by a hook in the apex and a force transducer. The latter was constructed not to measure force of contraction in an isometric manner, but rather auxotonic. Thus it behaves like a spring and allows the heart to work (see above). We are aware that this setup is not optimal in terms of muscle physiology, but installation of a balloon in the left ventricular cavity of a neonatal rat heart, one-third of the size of a mouse heart, is technically demanding and not suitable for screening purposes (at present 4 hearts are run in parallel). Given the well-developed inotropic response to isoprenaline (Fig. 6B) we feel that the present setup is a good alternative.

When compared with existing experimental ex vivo systems, the 24-h perfused neonatal rat heart has certain advantages and disadvantages that should be taken into consideration when designing an experiment. Whereas it is clearly more laborious than culturing and infecting neonatal or adult cardiac myocytes, it undoubtedly allows better functional evaluation of contractile parameters. This new method is easier to perform and control (in a reproducible manner) than the model of direct virus injections in the living heart or the cultured trabeculae system in which sufficient transfection efficiencies are only obtained with >100 times more virus (17). We feel that particularly the ease of virus infection, the reproducibility of high transfection rates at low titers, and the absence of signs of virus toxicity are important advantages. With one virus preparation from 40 dishes (145 mm) of HEK cells, we routinely get 1 x 1011 bavs. Thus ~100 hearts can be studied with one virus preparation. The latter can be thoroughly titered, which is critical for quantitative statements and comparison of different experiments. Another advantage is the efficiency in terms of animal usage. Existing cell isolation methods yield about 2 x 106 cells/neonatal rat heart, the number of cells necessary to plate one 60-mm cell culture dish at high density. A principal advantage of the intact heart is that cardiac myocyte function can be studied in the intact three-dimensional context, devoid of the confounding factors of cell isolation. Finally, it integrates the function of the entire cardiac cell population, whereas isolated cells necessarily represent a selection of cells that survive the harsh conditions of enzymatic cell isolation.

In conclusion, the new model should allow studies on the function of genes in a cardiac context and the impact of quantitative changes in gene expression. As such, it may be a useful complementation of existing experimental models.


    DISCLOSURES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
This study was supported by the German Ministry for Education and Research to T. Eschenhagen (collaborative project with Medigene, Martinsried, Germany) and by the German Research Foundation (DFG GRK 750).


    ACKNOWLEDGMENTS
 
We thank Thomas Müller and Johann Hügel for excellent technical support and ideas for the construction of the setup device.The results are part of the doctoral thesis of S. Wiechert and have been published in abstract form (Eur Heart J Suppl 23: 675, 2002).


    FOOTNOTES
 

Address for reprint requests and other correspondence: T. Eschenhagen, Martinistr. 52, 20246 Hamburg, Germany (E-mail: t.eschenhagen{at}uke.uni-hamburg.de).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 

  1. Bert P. Lecons sur la Physiologie Comparee de la Respiration. Paris: Baillere, 1870.
  2. Bishop SP, Anderson PG, and Tucker DC. Morphological development of the rat heart growing in oculo in the absence of hemodynamic work load. Circ Res 66: 84–102, 1990.[Abstract/Free Full Text]
  3. Chiche JD, Cariou A, and Mira JP. Bench-to-bedside review: fulfilling promises of the Human Genome Project. Crit Care 6: 212–215, 2002.[Web of Science][Medline]
  4. Christensen G, Minamisawa S, Gruber PJ, Wang Y, and Chien KR. High-efficiency, long-term cardiac expression of foreign genes in living mouse embryos and neonates. Circulation 101: 178–184, 2000.[Abstract/Free Full Text]
  5. Davia K, Hajjar RJ, Terracciano CM, Kent NS, Ranu HK, O'Gara P, Rosenzweig A, and Harding SE. Functional alterations in adult rat myocytes after overexpression of phospholamban with use of adenovirus. Physiol Genomics 1: 41–50, 1999.[Abstract/Free Full Text]
  6. del Monte F, Harding SE, Dec GW, Gwathmey JK, and Hajjar RJ. Targeting phospholamban by gene transfer in human heart failure. Circulation 105: 904–907, 2002.[Abstract/Free Full Text]
  7. Ditz D, Pamminger T, El-Armouche A, and Eschenhagen T. Effect of green fluorescent protein encoding adenoviral vectors on contractility in cardiac myocytes. Naunyn Schmiedebergs Arch Pharmacol 365: R1–R164, 2002.
  8. Donahue JK, Kikkawa K, Thomas AD, Marban E, and Lawrence JH. Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin. Gene Ther 5: 630–634, 1998.[Web of Science][Medline]
  9. Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, Weil J, Zimmermann W, Dohmen HH, Schafer H, Bishopric N, Wakatsuki T, and Elson EL. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J 11: 683–694, 1997.[Abstract]
  10. Fazekas JF, Alexander FAD, and Himwich HE. Tolerance of the newborn to anoxia. Am J Physiol 134: 281–287, 1941.[Free Full Text]
  11. Giordano FJ, He H, McDonough P, Meyer M, Sayen MR, and Dillmann WH. Adenovirus-mediated gene transfer reconstitutes depressed sarcoplasmic reticulum Ca2+-ATPase levels and shortens prolonged cardiac myocyte Ca2+ transients. Circulation 96: 400–403, 1997.[Abstract/Free Full Text]
  12. Hajjar RJ, Schmidt U, Matsui T, Guerrero JL, Lee KH, Gwathmey JK, Dec GW, Semigran MJ, and Rosenzweig A. Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA 95: 5251–5256, 1998.[Abstract/Free Full Text]
  13. Hwang JJ, Dzau VJ, and Liew CC. Genomics and the pathophysiology of heart failure. Curr Cardiol Rep 3: 198–207, 2001.[Medline]
  14. Janssen PM, Lehnart SE, Prestle J, Lynker JC, Salfeld P, Just H, and Hasenfuss G. The trabecula culture system: a novel technique to study contractile parameters over a multiday time period. Am J Physiol Heart Circ Physiol 274: H1481–H1488, 1998.[Abstract/Free Full Text]
  15. Kimura S and Gonzalez FJ. Applications of genetically manipulated mice in pharmacogenetics and pharmacogenomics. Pharmacology 61: 147–153, 2000.[Web of Science][Medline]
  16. Kirshenbaum LA, MacLellan WR, Mazur W, French BA, and Schneider MD. Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus. J Clin Invest 92: 381–387, 1993.[Web of Science][Medline]
  17. Lehnart SE, Janssen PM, Franz WM, Donahue JK, Lawrence JH, Marban E, Prestle J, and Hasenfuss G. Preservation of myocardial function after adenoviral gene transfer in isolated myocardium. Am J Physiol Heart Circ Physiol 279: H986–H991, 2000.[Abstract/Free Full Text]
  18. Logeart D, Hatem SN, Rucker-Martin C, Chossat N, Nevo N, Haddada H, Heimburger M, Perricaudet M, and Mercadier JJ. Highly efficient adenovirus-mediated gene transfer to cardiac myocytes after single-pass coronary delivery. Hum Gene Ther 11: 1015–1022, 2000.[Web of Science][Medline]
  19. O'Shaughnessy KM. The genetics of essential hypertension. Br J Clin Pharmacol 51: 5–11, 2001.[Web of Science][Medline]
  20. Sutherland FJ and Hearse DJ. The isolated blood and perfusion fluid perfused heart. Pharmacol Res 41: 613–627, 2000.[Web of Science][Medline]
  21. Woo-Ming M, Wu NM, Lester JL, III, and Malinin TI. Water content of hearts perfused with crystalloid and nutrient solutions. J Mol Cell Cardiol 12: 371–386, 1980.[Web of Science][Medline]
  22. Yamamoto A, Hen R, and Dauer WT. The ons and offs of inducible transgenic technology: a review. Neurobiol Dis 8: 923–932, 2001.[Web of Science][Medline]
  23. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, and Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 68: 106–114, 2000.[Web of Science][Medline]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. Stein, T. A.B. van Veen, C. A. Remme, M. Boulaksil, M. Noorman, L. van Stuijvenberg, R. van der Nagel, C. R. Bezzina, R. N.W. Hauer, J. M.T. de Bakker, et al.
Combined reduction of intercellular coupling and membrane excitability differentially affects transverse and longitudinal cardiac conduction
Cardiovasc Res, July 1, 2009; 83(1): 52 - 60.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/2/H907    most recent
00856.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiechert, S.
Right arrow Articles by Eschenhagen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiechert, S.
Right arrow Articles by Eschenhagen, T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.